A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes - PubMed (original) (raw)
A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes
J K Yee et al. Proc Natl Acad Sci U S A. 1994.
Abstract
Retroviral vectors have been central components in many studies leading to human gene therapy. However, the generally low titers and inefficient infectivity of retroviral vectors in human cells have limited their use. We previously reported that the G protein of vesicular stomatitis virus can serve as the exclusive envelope protein component for one specific retroviral vector, LGRNL, that expresses vesicular stomatitis virus G. We now report a more useful general transient transfection scheme for producing very high-titer vesicular stomatitis virus G-enveloped pseudotypes from any Moloney murine leukemia-based retroviral vector without having to rely on the expression of the cytotoxic G protein from the retroviral vector itself. We also demonstrate very high efficiency of infection with a pseudotyped lacZ vector in primary mouse hepatocytes. We suggest that pseudotyped retroviral vectors carrying reporter genes will permit genetic studies in many previously inaccessible vertebrate and invertebrate systems. Furthermore, because these vectors represent retroviral vectors of sufficiently high titer to allow efficient direct retroviral-mediated in vivo gene transfer, we also suggest that pseudotyped vectors carrying potentially therapeutic genes will become useful to test the potential for in vivo gene therapy.
Similar articles
- Pantropic retroviral vector integration, expression, and germline transmission in medaka (Oryzias latipes).
Lu JK, Burns JC, Chen TT. Lu JK, et al. Mol Mar Biol Biotechnol. 1997 Dec;6(4):289-95. Mol Mar Biol Biotechnol. 1997. PMID: 9418287 - Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Burns JC, et al. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7. doi: 10.1073/pnas.90.17.8033. Proc Natl Acad Sci U S A. 1993. PMID: 8396259 Free PMC article. - A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
Ory DS, Neugeboren BA, Mulligan RC. Ory DS, et al. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11400-6. doi: 10.1073/pnas.93.21.11400. Proc Natl Acad Sci U S A. 1996. PMID: 8876147 Free PMC article. - Generation of high-titer pseudotyped retroviral vectors with very broad host range.
Yee JK, Friedmann T, Burns JC. Yee JK, et al. Methods Cell Biol. 1994;43 Pt A:99-112. doi: 10.1016/s0091-679x(08)60600-7. Methods Cell Biol. 1994. PMID: 7823872 Review. - Development of HIV vectors for anti-HIV gene therapy.
Poeschla E, Corbeau P, Wong-Staal F. Poeschla E, et al. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11395-9. doi: 10.1073/pnas.93.21.11395. Proc Natl Acad Sci U S A. 1996. PMID: 8876146 Free PMC article. Review.
Cited by
- Elasticity of the HIV-1 core facilitates nuclear entry and infection.
Deshpande A, Bryer AJ, Andino-Moncada JR, Shi J, Hong J, Torres C, Harel S, Francis AC, Perilla JR, Aiken C, Rousso I. Deshpande A, et al. PLoS Pathog. 2024 Sep 11;20(9):e1012537. doi: 10.1371/journal.ppat.1012537. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39259747 Free PMC article. - Imaging HIV-1 Nuclear Import, Uncoating, and Proviral Transcription.
Burdick RC, Duchon A, Hu WS, Pathak VK. Burdick RC, et al. Methods Mol Biol. 2024;2807:15-30. doi: 10.1007/978-1-0716-3862-0_2. Methods Mol Biol. 2024. PMID: 38743218 - HIV-1 uncoating requires long double-stranded reverse transcription products.
Burdick RC, Morse M, Rouzina I, Williams MC, Hu WS, Pathak VK. Burdick RC, et al. Sci Adv. 2024 Apr 26;10(17):eadn7033. doi: 10.1126/sciadv.adn7033. Epub 2024 Apr 24. Sci Adv. 2024. PMID: 38657061 Free PMC article. - Expression of a large coding sequence: Gene therapy vectors for Ataxia Telangiectasia.
Hirch T, Brander N, Schenk F, Pöllmann SJ, Reichenbach J, Schubert R, Modlich U. Hirch T, et al. Sci Rep. 2023 Nov 8;13(1):19386. doi: 10.1038/s41598-023-46332-4. Sci Rep. 2023. PMID: 37938627 Free PMC article. - Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G.
Delviks-Frankenberry KA, Ojha CR, Hermann KJ, Hu WS, Torbett BE, Pathak VK. Delviks-Frankenberry KA, et al. Mol Ther Nucleic Acids. 2023 Aug 11;33:794-809. doi: 10.1016/j.omtn.2023.08.007. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37662965 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6 - PubMed
- Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8033-7 - PubMed
- Blood. 1994 Jan 1;83(1):43-50 - PubMed
- Nat Genet. 1994 Apr;6(4):335-41 - PubMed
- J Gen Virol. 1972 Jun;15(3):183-91 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials